Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01834404 · ClinicalTrials.gov registry record · Phase 4
Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT01834404: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT01834404 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01834404, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
Our overall goal is to determine the effect of Phentermine and Topiramate ER on gastric emptying, gastric accommodation, satiety, and satiation in obese participants.
Interventions
- DRUG Placebo
- DRUG Phentermine-Topiramate ER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01834404
The ClinicalTrials.gov registry entry for NCT01834404 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01834404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01834404 about?
NCT01834404 is a clinical study titled "Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients". Our overall goal is to determine the effect of Phentermine and Topiramate ER on gastric emptying, gastric accommodation, satiety, and satiation in obese participants.
What is the current status of trial NCT01834404?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2013-04. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01834404?
The interventions under investigation include: Placebo (DRUG), Phentermine-Topiramate ER (DRUG).
Who is sponsoring clinical trial NCT01834404?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.